Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
19%
Adverse Event
27%
All Cause Mortality
43%
Anticarcinogen
53%
Antidiabetic Agent
29%
Antiviral Drug
21%
Bisphosphonic Acid Derivative
26%
Brain Ischemia
20%
Breast Cancer
52%
Cancer Mortality
34%
Cardiovascular Disease
62%
Chemotherapy Regimens
44%
Chronic Kidney Failure
36%
Clinical Research
40%
Cohort Study
78%
Comorbidity
42%
Diabetes Mellitus
32%
Diseases
41%
Drug Utilization
37%
Erlotinib
21%
Febrile Neutropenia
40%
Fragility Fracture
22%
Granulocyte Colony Stimulating Factor
34%
Heart Infarction
21%
Hip Fracture
71%
Hypertension
24%
Immune Checkpoint Inhibitor
34%
Infection
25%
Kidney Disease
23%
Lung Cancer
54%
Malignant Neoplasm
100%
Metastatic Colorectal Cancer
34%
Molnupiravir
34%
Monotherapy
20%
Nirmatrelvir
34%
Non Small Cell Lung Cancer
44%
Observational Study
64%
Overall Survival
34%
Pancreas Cancer
34%
Pioglitazone
26%
Prevalence
24%
Progression Free Survival
19%
Regorafenib
34%
Retrospective Study
38%
Ritonavir
34%
Rosiglitazone
25%
sodium glucose cotransporter-2 inhibitors
52%
Spine Fracture
68%
Thiazolidinedione
34%
Zoledronic Acid
24%
Medicine and Dentistry
Adverse Event
35%
Antiviral Drug
19%
Antivirus Agent
18%
Area under the Curve
40%
Artificial Intelligence
26%
Body Mass Index
26%
Breast Cancer
24%
Cancer
19%
Cancer Therapy
52%
Clinical Research
26%
Cohort Analysis
74%
Comorbidity
28%
COVID-19
86%
Diabetes
22%
Diseases
20%
Electronic Health Record
21%
Endoscopy
23%
Epidermal Growth Factor Receptor
25%
Erlotinib
33%
Fragility Fracture
21%
Gefitinib
33%
Glucagon-Like Peptide-1 Agonist
20%
Hazard Ratio
31%
Health Care Cost
35%
Hip Fracture
46%
Infection
30%
Logistic Regression Analysis
24%
Lung Cancer
19%
Lung Cancer Survival
34%
Machine Learning Algorithm
23%
Malignant Neoplasm
30%
Maturity Onset Diabetes of the Young
34%
Meta-Analysis
19%
Network Meta-Analysis
17%
Nirmatrelvir
34%
Non Small Cell Lung Cancer
33%
Observational Study
38%
Odds Ratio
27%
Oral
38%
Osteoporosis
69%
Prediction Model
60%
Proton-Pump Inhibitor
19%
Quality of Life
19%
Real-World Data
22%
Ritonavir
34%
Spine Fracture
60%
Systematic Review
52%
Targeted Therapy
52%
Time Series Analysis
52%
Visual Analog Scale
23%
Nursing and Health Professions
Acute Heart Infarction
17%
Adverse Event
17%
Area under the Curve
43%
Artificial Intelligence
21%
Artificial Neural Network
33%
Breast Cancer
55%
Cancer Diagnosis
17%
Cancer Mortality
34%
Cancer Survival
34%
Cancer Therapy
23%
Cardiovascular Disease
28%
Chronic Kidney Failure
17%
Cohort Analysis
59%
Combination Therapy
18%
Confidence Interval
18%
COVID-19
86%
Diseases
21%
Electronic Health Record
38%
Febrile Neutropenia
17%
Food and Drug Administration
19%
Health Inequality
17%
Hip Fracture
28%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
17%
Hypertension
19%
Infection
30%
Infertility Therapy
17%
Logistic Regression Analysis
27%
Longitudinal Analysis
17%
Lung Cancer
34%
Malignant Neoplasm
22%
Maturity Onset Diabetes of the Young
17%
National Health Insurance
29%
Odds Ratio
21%
Patient Care
23%
Pilot Study
17%
Pioglitazone
22%
Public Hospital
17%
Receiver Operating Characteristic
21%
Ritonavir
34%
Rosiglitazone
22%
Social Media
17%
Spine Fracture
43%
Statin (Protein)
17%
Systematic Review
17%
Teleconsultation
17%
Thiazolidinedione
34%
Thorax Pain
17%
Time Series Analysis
22%
Validation Study
17%
Visual Analog Scale
23%
